Page last updated: 2024-09-03

cimadronate and ethylmaleimide

cimadronate has been researched along with ethylmaleimide in 1 studies

Compound Research Comparison

Studies (cimadronate)	Trials (cimadronate)	Recent Studies (post-2010) (cimadronate)	Studies (ethylmaleimide)	Trials (ethylmaleimide)	Recent Studies (post-2010) (ethylmaleimide)
105	3	4	6,136	3	226

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barbier, A; Baron, R; David, P; Nguyen, H	1

Other Studies

1 other study(ies) available for cimadronate and ethylmaleimide

Article	Year
The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1996, Volume: 11, Issue:10 Topics: Alendronate; Animals; Binding, Competitive; Bone Resorption; Cell Membrane Permeability; Chickens; Diphosphonates; Dose-Response Relationship, Drug; Ethylmaleimide; Etidronic Acid; Female; Hydrogen-Ion Concentration; Kidney; Lethal Dose 50; Osteoclasts; Proton-Translocating ATPases; Saccharomyces cerevisiae; Synaptic Vesicles	1996

Article

Year

The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1996, Volume: 11, Issue:10

Topics: Alendronate; Animals; Binding, Competitive; Bone Resorption; Cell Membrane Permeability; Chickens; Diphosphonates; Dose-Response Relationship, Drug; Ethylmaleimide; Etidronic Acid; Female; Hydrogen-Ion Concentration; Kidney; Lethal Dose 50; Osteoclasts; Proton-Translocating ATPases; Saccharomyces cerevisiae; Synaptic Vesicles

1996